{
    "clinical_study": {
        "@rank": "67118", 
        "acronym": "PANTHER", 
        "arm_group": {
            "arm_group_label": "Unipolar major depression", 
            "description": "Outpatients Individuals between 18 and 75 years old with a current episode of non-psychotic unipolar major depression that are treated with an antidepressant drug according to physician\u00b4s current and usual practice."
        }, 
        "brief_summary": {
            "textblock": "A non interventional, descriptive, longitudinal cohort study is designed, trying to obtain\n      local data about the prevalence of non remitted depressed patients after an antidepressant\n      treatment, and to get information about sociodemographic and clinical characteristics of\n      these patients as well as features of their treatments and compare them with those of the\n      patients that achieve remission. Also the effect of patient\u00b4s expectation in the treatment\n      outcome will be examined."
        }, 
        "brief_title": "Prevalence and Risk Factors in Unipolar Depression Patients Without Remission After One Antidepressant Trial", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Non-psychotic Unipolar Major Depression", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Depressive Disorder, Major"
            ]
        }, 
        "detailed_description": {
            "textblock": "A non interventional, descriptive, longitudinal cohort study is designed, trying to obtain\n      local data about the prevalence of non remitted depressed patients after an antidepressant\n      treatment, and to get information about sociodemographic and clinical characteristics of\n      these patients as well as features of their treatments and compare them with those of the\n      patients that achieve remission. Also the effect of patient\u00b4s expectation in the treatment\n      outcome will be examined.\n\n      Non psychotic depressed patients that are initiating an antidepressant treatment will be\n      recruited. Socio demographic and clinical features will be recorded as well as their\n      expectations before the treatment. Severity of depression and treatment characteristics will\n      be recorded after 4 to 8 weeks of drug treatment at an adequate dose. Variables will be\n      compared between the patients that will achieve remission and those that do not."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Female and  male aged 18 to 75 years old. Outpatients with a current episode of\n        non-psychotic unipolar major depression according to the DSM IV-TR.\n\n        Severity of illness assessed by means of a score \u2265 14 in the HAM D17 Have not been\n        medicated for the current depression episode with an antidepressant Provision of subject\n        informed consent\n\n        Exclusion Criteria:\n\n        Patients participating in any clinical trial, the subject cannot take part in this study.\n\n        The individual has participated in the last 3 months (including this study) or is\n        participating in a clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Individuals between 18 and 75 years old that have non-psychotic unipolar major depression\n        and  have not been treated for the current episode."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01887639", 
            "org_study_id": "NIS-NAR-XXX-2013/1"
        }, 
        "intervention_browse": {
            "mesh_term": "Antidepressive Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Non-psychotic unipolar major depression", 
            "Resistant depression"
        ], 
        "lastchanged_date": "February 27, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caba", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caba", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chaco", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cordoba", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rosario", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rosario", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Salvador de Jujuy", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Fe", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tucuman", 
                        "country": "Argentina"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Argentina"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prevalence and Risk Factors in Unipolar Depression Patients Without Remission After One Antidepressant Trial: PANTHER Study", 
        "overall_contact": {
            "email": "martin.plotquin@astrazeneca.com", 
            "last_name": "Martin Plotquin, MD", 
            "phone": "5411 4460 9246"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Argentina: Human Research Bioethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Non psychotic depressed patients that are initiating an antidepressant treatment will be recruited. Socio demographic and clinical features will be recorded as well as their expectations before the treatment. Severity of depression and treatment characteristics will be recorded after drug treatment at an adequate dose. Variables will be compared between the patients that will achieve remission and those that do not.", 
            "measure": "Percentage of patients with unipolar major depression that do not achieve remission after one antidepressant treatment.", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01887639"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Description of the clinical (Clinical history, episode features, BDI and HAM D17 scores), therapeutic (Type of drug, dose used, treatment period, adherence, presence and type of psychosocial therapy) and socio-demographic (age, gender, civil status, employment status, cohabitation, health insurance) characteristics of resistant depression patients and to compare them with the characteristics of the sample of depressed patients in remission.", 
                "measure": "Clinical, therapeutic and socio-demographic characteristics of resistant depression patients and comparisson of them with the characteristics of the sample of depressed patients in remission.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Comparison of the  depression severity change assessed by the physician with the evaluation done by the patient by means of the BDI.", 
                "measure": "Comparison of the  depression severity change assessed by the physician with the evaluation done by the patient", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "12 Weeks", 
        "verification_date": "February 2014"
    }
}